Investing.com -- DexCom (NASDAQ:DXCM) stock fell 4% Tuesday after a concerning report from Hunterbrook detailed multiple deaths allegedly linked to the company’s G7 continuous glucose monitor.

Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It announced today ...

A gentle flicker of light and a steady hum of sound might help slow the course of Alzheimer’s disease. That’s the idea behind ...

Google’s Quantum Echoes now closes the loop: verification has become a measurable force, a resonance between consciousness and method. The many worlds seem to be bleeding together. Each observation is ...

TrialWear was invented by Elizabeth Johnson, an assistant professor in MSU’s Mark and Robyn Jones College of Nursing.

At an extravagant reception, hotelier Steve Farzam seemed to literally plunge into marriage, appearing to dive from a helicopter in a rainbow parachute onto the grounds of a luxury hotel north of ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

The Federal Government’s recent directive mandating all Ministries, Departments and Agencies (MDAs), as well as private employers ...

Foundation Medicine, Inc., a precision medicine company transforming lives in cancer care and beyond, today announced a partnership with Manifold, the leading artificial intelligence (AI) data ...

D excom (DXCM) shares slipped in midday trade on Tuesday after short seller Hunterbrook reported three additional deaths ...

Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial ...